Therapeutic advances in myocardial microvascular resistance: Unravelling the enigma

Pharmacology and Therapeutics

Volumn 127, Issue 2, 2010, Pages 131-147

  Patel, Billal ^a   Fisher, Michael ^a,b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Acute coronary syndrome; Angina; Coronary angioplasty; Microvascular dysfunction; Myocardial infarction; No reflow

Indexed keywords

ADENOSINE; ATORVASTATIN; FIBRINOGEN RECEPTOR ANTAGONIST; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; NITROPRUSSIDE SODIUM; VERAPAMIL;

CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART MUSCLE METABOLISM; HEART MUSCLE REVASCULARIZATION; HUMAN; MICROCIRCULATION; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR RESISTANCE; ACUTE CORONARY SYNDROME; ANIMAL; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROCEDURES;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; HUMANS; MICROCIRCULATION; MYOCARDIAL INFARCTION; ANGIOPLASTY, BALLOON, CORONARY;

EID: 77954242261     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2010.04.014     Document Type: Review

References (225)

1. Aarnoudse W., Fearon W.F., Manoharan G., Geven M., van d V., Rutten M., De B.B., Pijls N.H. Epicardial stenosis severity does not affect minimal microcirculatory resistance. Circulation 2004, 110:2137-2142.
2. Abdelmeguid A.E., Topol E.J., Whitlow P.L., Sapp S.K., Ellis S.G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996, 94:1528-1536.
3. Albertal M., Voskuil M., Piek J.J., de B.B., Van L.G., Kay P.I., Costa M.A., Boersma E., Beijsterveldt T., Sousa J.E., Belardi J.A., Serruys P.W. Coronary flow velocity reserve after percutaneous interventions is predictive of periprocedural outcome. Circulation 2002, 105:1573-1578.
4. Amit G., Cafri C., Yaroslavtsev S., Fuchs S., Paltiel O., bu-Ful A., Weinstein J.M., Wolak A., Ilia R., Zahger D. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute MI. A randomized, double-blind, placebo-controlled clinical trial. Am Heart J 2006, 152:887.
5. Angelini A., Rubartelli P., Mistrorigo F., Della B.M., Abbadessa F., Vischi M., Thiene G., Chierchia S. Distal protection with a filter device during coronary stenting in patients with stable and unstable angina. Circulation 2004, 110:515-521.
6. Armstrong R. The physiological role and pharmacological potential of nitric oxide in neutrophil activation. Int Immunopharmacol 2001, 1:1501-1512.
7. Aymong E.D., Curtis M.J., Youssef M., Graham M.M., Shewchuk L., Leschuk W., Anderson T.J. Abciximab attenuates coronary microvascular endothelial dysfunction after coronary stenting. Circulation 2002, 105:2981-2985.
8. Bates E.R., Krell M.J., Dean E.N., O'Neill W.W., Vogel R.A. Demonstration of the "no-reflow" phenomenon by digital coronary arteriography. Am J Cardiol 1986, 57:177-178.
9. Beanlands R.S., Muzik O., Melon P., Sutor R., Sawada S., Muller D., Bondie D., Hutchins G.D., Schwaiger M. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity. J Am Coll Cardiol 1995, 26:1465-1475.
10. Berne R.M. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 1963, 204:317-322.
11. Berne R.M. The role of adenosine in the regulation of coronary blood flow. Circ Res 1980, 47:807-813.
12. Bernstein R.D., Ochoa F.Y., Xu X., Forfia P., Shen W., Thompson C.I., Hintze T.H. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res 1996, 79:840-848.
13. Bing R.J., Hellems H.K., Regan T.J. Measurement of coronary blood flow in man. Circulation 1960, 22:1-3.
14. Bonderman D., Teml A., Jakowitsch J., Adlbrecht C., Gyongyosi M., Sperker W., Lass H., Mosgoeller W., Glogar D.H., Probst P., Maurer G., Nemerson Y., Lang I.M. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. Blood 2002, 99:2794-2800.
15. Bowles D.K., Hu Q., Laughlin M.H., Sturek M. Heterogeneity of L-type calcium current density in coronary smooth muscle. Am J Physiol 1997, 273:H2083-H2089.
16. Briguori C., Colombo A., Airoldi F., Violante A., Focaccio A., Balestrieri P., Paolo E.P., Golia B., Lepore S., Riviezzo G., Scarpato P., Librera M., Bonizzoni E., Ricciardelli B. Statin administration before percutaneous coronary intervention: impact on periprocedural MI. Eur Heart J 2004, 25:1822-1828.
17. Briguori C., Visconti G., Focaccio A., Golia B., Chieffo A., Castelli A., Mussardo M., Montorfano M., Ricciardelli B., Colombo A. Novel approaches for preventing or limiting events (NAPLES) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction http://dx.doi.org/10.1016/j.jacc.2009.07.005.
18. Brodie B.R., Stone G.W., Cox D.A., Stuckey T.D., Turco M., Tcheng J.E., Berger P., Mehran R., McLaughlin M., Costantini C., Lansky A.J., Grines C.L. Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute MI: analysis from the CADILLAC trial. Am Heart J 2006, 151:1231-1238.
19. Butter W.J., Ostrander L.D., Carman W.J., Lamphier D.E. Mortality from coronary heart disease in the Tecumseh study: long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol 1985, 121:541-547.
20. Camici P., Chiriatti G., Lorenzoni R., Bellina R.C., Gistri R., Italiani G., Parodi O., Salvadori P.A., Nista N., Papi L. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991, 17:879-886.
21. Camici P.G., Marraccini P., Gistri R., Salvadori P.A., Sorace O., L'Abbate A. Adrenergically mediated coronary vasoconstriction in patients with syndrome X. Cardiovasc Drugs Ther 1994, 8:221-226.
22. Cannon R.O., Epstein S.E. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988, 61:1338-1343.
23. Cecchi F., Olivotto I., Gistri R., Lorenzoni R., Chiriatti G., Camici P.G. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003, 349:1027-1035.
24. Chamuleau S.A., Siebes M., Meuwissen M., Koch K.T., Spaan J.A., Piek J.J. Association between coronary lesion severity and distal microvascular resistance in patients with coronary artery disease. Am J Physiol Heart Circ Physiol 2003, 285:H2194-H2200.
25. Chan A.W., Bhatt D.L., Chew D.P., Quinn M.J., Moliterno D.J., Topol E.J., Ellis S.G. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation 2002, 105:691-696.
26. Chareonthaitawee P., Kaufmann P.A., Rimoldi O., Camici P.G. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001, 50:151-161.
27. Chauhan A., Mullins P.A., Taylor G., Petch M.C., Schofield P.M. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J 1997, 18:60-68.
28. Chen G., Suzuki H., Weston A.H. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol 1988, 95:1165-1174.
29. Chilian W.M., Eastham C.L., Marcus M.L. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol 1986, 251:H779-H788.
30. Cornelissen A.J., Dankelman J., VanBavel E., Stassen H.G., Spaan J.A. Myogenic reactivity and resistance distribution in the coronary arterial tree: a model study. Am J Physiol Heart Circ Physiol 2000, 278:H1490-H1499.
31. Crea F., Lanza G.A. Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 2004, 90:457-463.
32. Crisostomo P.R., Wairiuko G.M., Wang M., Tsai B.M., Morrell E.D., Meldrum D.R. Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J Am Coll Surg 2006, 202:797-812.
33. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994, 76:5-13.
34. Cuisset T., Hamilos M., Melikian N., Wyffels E., Sarma J., Sarno G., Barbato E., Bartunek J., Wijns W., De B.B. Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation. J Am Coll Cardiol 2008, 51:1060-1065.
35. Cura F.A., Escudero A.G., Berrocal D., Mendiz O., Trivi M.S., Fernandez J., Palacios A., Albertal M., Piraino R., Riccitelli M.A., Gruberg L., Ballarino M., Milei J., Baeza R., Thierer J., Grinfeld L., Krucoff M., O'Neill W., Belardi J. Protection of distal embolization in high-risk patients with acute ST-segment elevation MI (PREMIAR). Am J Cardiol 2007, 99:357-363.
36. Davis M.J., Hill M.A. Signalling mechanisms underlying the vascular myogenic response. Physiol Rev 1999, 79:387-423.
37. Davis M.J., Donovitz J.A., Hood J.D. Stretch-activated single-channel and whole cell currents in vascular smooth muscle cells. Am J Physiol 1992, 262:C1083-C1088.
38. De B.B., Pijls N.H., Smith L., Wievegg M., Heyndrickx G.R. Coronary thermodilution to assess flow reserve: experimental validation. Circulation 2001, 104:2003-2006.
39. Di Carli M.F., Janisse J., Grunberger G., Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003, 41:1387-1393.
40. Dole W.P., Yamada N., Bishop V.S., Olsson R.A. Role of adenosine in coronary blood flow regulation after reductions in perfusion pressure. Circ Res 1985, 56:517-524.
41. Doucette J.W., Corl P.D., Payne H.M., Flynn A.E., Goto M., Nassi M., Segal J. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992, 85:1899-1911.
42. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., Gotto A.M. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998, 279:1615-1622.
43. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., Zieve F.J., Marks J., Davis S.N., Hayward R., Warren S.R., Goldman S., McCarren M., Vitek M.E., Henderson W.G., Huang G.D., the V A D T, I, Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129-139.
44. + Channel Blockade. J Clin Invest 1995, 95:285-295.
45. Egashira K., Katsuda Y., Mohri M., Kuga T., Tagawa T., Kubota T., Hirakawa Y., Takeshita A. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ Res 1996, 79:331-335.
46. Falsetti H.L., Carroll R.J., Marcus M.L. Temporal heterogeneity of myocardial blood flow in anesthetized dogs. Circulation 1975, 52:848-853.
47. Fearon W.F., Balsam L.B., Farouque H.M., Caffarelli A.D., Robbins R.C., Fitzgerald P.J., Yock P.G., Yeung A.C. Novel index for invasively assessing the coronary microcirculation. Circulation 2003, 107:3129-3132.
48. Fearon W.F., Aarnoudse W., Pijls N.H., De B.B., Balsam L.B., Cooke D.T., Robbins R.C., Fitzgerald P.J., Yeung A.C., Yock P.G. Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: experimental validation. Circulation 2004, 109:2269-2272.
49. Fearon W.F., Shah M., Ng M., Brinton T., Wilson A., Tremmel J.A., Schnittger I., Lee D.P., Vagelos R.H., Fitzgerald P.J., Yock P.G., Yeung A.C. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation MI. J Am Coll Cardiol 2008, 51:560-565.
50. Feletou M., Vanhoutte P.M. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988, 93:515-524.
51. Fischell T.A., Carter A.J., Foster M.T., Hempsall K., DeVries J., Kim D.H., Kloostra A. Reversal of "no reflow" during vein graft stenting using high velocity boluses of intracoronary adenosine. Cathet Cardiovasc Diagn 1998, 45:360-365.
52. Folts J.D., Rowe G.G., Kahn D.R., Young W.P. Phasic changes in human right coronary blood flow before and after repair of aortic insufficiency. Am Heart J 1979, 97:211-215.
53. Franklin D.L., Schlegel W., Rushmer R.F. Blood flow measured by Doppler frequency shift of back-scattered ultrasound. Science 1961, 134:564-565.
54. Fujii M., Chambers D.J. Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role?. Eur J Cardiothorac Surg 2005, 28:821-831.
55. Galassi A.R., Kaski J.C., Pupita G., Vejar M., Crea F., Maseri A. Lack of evidence for alpha-adrenergic receptor-mediated mechanisms in the genesis of ischemia in syndrome X. Am J Cardiol 1989, 64:264-269.
56. Galie N., Guarnieri C., Ussia G.P., Zimarino M., Traini A.M., Parlangeli R., Vaona I., Branzi A., Magnani B. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J Cardiovasc Pharmacol 1995, 26:477-484.
57. Gibson C.M., Cannon C.P., Murphy S.A., Ryan K.A., Mesley R., Marble S.J., McCabe C.H., Van De W.F., Braunwald E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000, 101:125-130.
58. Gibson C.M., Cohen D.J., Cohen E.A., Lui H.K., Murphy S.A., Marble S.J., Kitt M., Lorenz T., Tcheng J.E. Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Am J Cardiol 2001, 87:1293-1295.
59. Gick M., Jander N., Bestehorn H.P., Kienzle R.P., Ferenc M., Werner K., Comberg T., Peitz K., Zohlnhofer D., Bassignana V., Buettner H.J., Neumann F.J. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in MI with and without ST-segment elevation. Circulation 2005, 112:1462-1469.
60. Gorog D.A., Foale R.A., Malik I. Distal myocardial protection during percutaneous coronary intervention: when and where?. J Am Coll Cardiol 2005, 46:1434-1445.
61. Gould K.L., Lipscomb K., Hamilton G.W. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974, 33:87-94.
62. Gould K.L., Lipscomb K., Calvert C. Compensatory changes of the distal coronary vascular bed during progressive coronary constriction. Circulation 1975, 51:1085-1094.
63. Gould K.L., Kirkeeide R.L., Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990, 15:459-474.
64. Grech E.D., Ramsdale D.R. Termination of reperfusion arrhythmia by coronary artery occlusion. Br Heart J 1994, 72:94-95.
65. Gregorini L., Marco J., Kozakova M., Palombo C., Anguissola G.B., Marco I., Bernies M., Cassagneau B., Distante A., Bossi I.M., Fajadet J., Heusch G. Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute MI. Circulation 1999, 99:482-490.
66. Gregorini L., Marco J., Farah B., Bernies M., Palombo C., Kozakova M., Bossi I.M., Cassagneau B., Fajadet J., Di M.C., Albiero R., Cugno M., Grossi A., Heusch G. Effects of selective Alpha1- and Alpha2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation 2002, 106:2901-2907.
67. Guetta V., Mosseri M., Shechter M., Matetzky S., Assali A., Almagor Y., Gruberg L., Benderly M., Lotam C., Kornowski R. Safety and efficacy of the FilterWire EZ in acute ST-segment elevation MI. Am J Cardiol 2007, 99:911-915.
68. Hang C.L., Wang C.P., Yip H.K., Yang C.H., B-F Guo G., Wu C.J., Chen S.M. Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute MI. Chest 2005, 128:2593-2598.
69. Hausenloy D.J., Mwamure P.K., Venugopal V., Harris J., Barnard M., Grundy E., Ashley E., Vichare S., Di S.C., Kolvekar S., Hayward M., Keogh B., MacAllister R.J., Yellon D.M. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007, 370:575-579.
70. Hayat S.A., Patel B., Khattar R.S., Malik R.A. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 2004, 107:539-557.
71. Henriques J.P., Zijlstra F., Ottervanger J.P., de Boer M.J., van 't Hof A.W., Hoorntje J.C., Suryapranata H. Incidence and clinical significance of distal embolization during primary angioplasty for acute MI. Eur Heart J 2002, 23:1112-1117.
72. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 2005, 26:2493-2519.
73. Heusch G., Baumgart D., Camici P., Chilian W., Gregorini L., Hess O., Indolfi C., Rimoldi O. Alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation 2000, 101:689-694.
74. Hillegass W.B., Dean N.A., Liao L., Rhinehart R.G., Myers P.R. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol 2001, 37:1335-1343.
75. Hiramatsu O., Goto M., Yada T., Kimura A., Chiba Y., Tachibana H., Ogasawara Y., Tsujioka K., Kajiya F. In vivo observations of the intramural arterioles and venules in beating canine hearts. J Physiol 1998, 509(Pt 2):619-628.
76. Ibrahim T., Nekolla S.G., Schreiber K., Odaka K., Volz S., Mehilli J., Guthlin M., Delius W., Schwaiger M. Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol 2002, 39:864-870.
77. Ignarro L.J., Cirino G., Casini A., Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 1999, 34:879-886.
78. Ikeda N., Yasu T., Kubo N., Hashimoto S., Tsuruya Y., Fujii M., Kawakami M., Saito M. Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute MI. Heart 2004, 90:181-185.
79. Imamura Y., Tomoike H., Narishige T., Takahashi T., Kasuya H., Takeshita A. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am J Physiol 1992, 263:H399-H404.
80. + channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res 1998, 82:346-359.
81. Ishii H., Ichimiya S., Kanashiro M., Amano T., Imai K., Murohara T., Matsubara T. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation MI. Circulation 2005, 112:1284-1288.
82. Ito H., Tomooka T., Sakai N., Yu H., Higashino Y., Fujii K., Masuyama T., Kitabatake A., Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior MI. Circulation 1992, 85:1699-1705.
83. Ito H., Maruyama A., Iwakura K., Takiuchi S., Masuyama T., Hori M., Higashino Y., Fujii K., Minamino T. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall MI. Circulation 1996, 93:223-228.
84. Ito H., Okamura A., Iwakura K., Masuyama T., Hori M., Takiuchi S., Negoro S., Nakatsuchi Y., Taniyama Y., Higashino Y., Fujii K., Minamino T. Myocardial perfusion patterns related to thrombolysis in MI perfusion grades after coronary angioplasty in patients with acute anterior wall MI. Circulation 1996, 93:1993-1999.
85. Ito H., Taniyama Y., Iwakura K., Nishikawa N., Masuyama T., Kuzuya T., Hori M., Higashino Y., Fujii K., Minamino T. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall MI. J Am Coll Cardiol 1999, 33:654-660.
86. Ito H., Terai K., Iwakura K., Kawase I., Fujii K. Hemodynamics of microvascular dysfunction in patients with anterior wall acute MI. Am J Cardiol 2004, 94:209-212.
87. Jaber W.A., Yang E.H., Nishimura R.A., Sorajja P., Rihal C.S., Elesber A., Eeckhout E., Lerman A. Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Heart 2009, 95:564-569.
88. Jayaweera A.R., Edwards N., Glasheen W.P., Villanueva F.S., Abbott R.D., Kaul S. In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. comparison with radiolabeled red blood cells. Circ Res 1994, 74:1157-1165.
89. Jayaweera A.R., Wei K., Coggins M., Bin J.P., Goodman C., Kaul S. Role of capillaries in determining CBF reserve: new insights using myocardial contrast echocardiography. Am J Physiol 1999, 277:H2363-H2372.
90. Jesel L., Morel O., Ohlmann P., Germain P., Faure A., Jahn C., Coulbois P.M., Chauvin M., Bareiss P., Roul G. Role of pre-infarction angina and inflammatory status in the extent of microvascular obstruction detected by MRI in MI patients treated by PCI. Int J Cardiol 2007, 121:139-147.
91. Jones C.J., Kuo L., Davis M.J., Chilian W.M. Regulation of coronary blood flow: coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res 1995, 29:585-596.
92. Kanatsuka H., Lamping K.G., Eastham C.L., Dellsperger K.C., Marcus M.L. Comparison of the effects of increased myocardial oxygen consumption and adenosine on the coronary microvascular resistance. Circ Res 1989, 65:1296-1305.
93. Kanatsuka H., Lamping K.G., Eastham C.L., Marcus M.L. Heterogeneous changes in epimyocardial microvascular size during graded coronary stenosis. Evidence of the microvascular site for autoregulation. Circ Res 1990, 66:389-396.
94. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241:2035-2038.
95. Kaplan B.M., Benzuly K.H., Kinn J.W., Bowers T.R., Tilli F.V., Grines C.L., O'Neill W.W., Safian R.D. Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn 1996, 39:113-118.
96. Kaski J.C., Rosano G.M., Collins P., Nihoyannopoulos P., Maseri A., Poole-Wilson P.A. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995, 25:807-814.
97. Kassab G.S., Lin D.H., Fung Y.C. Morphometry of pig coronary venous system. Am J Physiol 1994, 267:H2100-H2113.
98. Kawai Y., Hisamatsu K., Matsubara H., Dan K., Akagi S., Miyaji K., Munemasa M., Fujimoto Y., Kusano K.F., Ohe T. Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon. Eur Heart J 2009, 30:765-772.
99. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute MI: a quantitative review of 23 randomised trials. Lancet 2003, 361:13-20.
100. Keller M.W., Segal S.S., Kaul S., Duling B. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res 1989, 65:458-467.
101. Kern M.J., Dupouy P., Drury J.H., Aguirre F.V., Aptecar E., Bach R.G., Caracciolo E.A., Donohue T.J., Rande J.L., Geschwind H.J., Mechem C.J., Kane G., Teiger E., Wolford T.L. Role of coronary artery lumen enlargement in improving coronary blood flow after balloon angioplasty and stenting: a combined intravascular ultrasound Doppler flow and imaging study. J Am Coll Cardiol 1997, 29:1520-1527.
102. Kern M.J., Puri S., Bach R.G., Donohue T.J., Dupouy P., Caracciolo E.A., Craig W.R., Aguirre F., Aptecar E., Wolford T.L., Mechem C.J., Dubois-Rande J.L. Abnormal coronary flow velocity reserve after coronary artery stenting in patients: role of relative coronary reserve to assess potential mechanisms. Circulation 1999, 100:2491-2498.
103. Kersten J.R., Brooks L.A., Dellsperger K.C. Impaired microvascular response to graded coronary occlusion in diabetic and hyperglycemic dogs. Am J Physiol 1995, 268:H1667-H1674.
104. Kilian J.G., Nakhla S., Sieveking D.P., Celermajer D.S. Adenosine prevents neutrophil adhesion to human endothelial cells after hypoxia/reoxygenation. Int J Cardiol 2005, 105:322-326.
105. King R.B., Bassingthwaighte J.B., Hales J.R., Rowell L.B. Stability of heterogeneity of myocardial blood flow in normal awake baboons. Circ Res 1985, 57:285-295.
106. Kitabata H., Imanishi T., Kubo T., Takarada S., Kashiwagi M., Matsumoto H., Tsujioka H., Ikejima H., Arita Y., Okochi K., Kuroi A., Ueno S., Kataiwa H., Tanimoto T., Yamano T., Hirata K., Nakamura N., Tanaka A., Mizukoshi M., Akasaka T. Coronary microvascular resistance index immediately after primary percutaneous coronary intervention as a predictor of the transmural extent of infarction in patients with ST-segment elevation anterior acute MI. JACC Cardiovasc Imaging 2009, 2:263-272.
107. Kloner R.A., Ganote C.E., Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974, 54:1496-1508.
108. Kloner R.A., Forman M.B., Gibbons R.J., Ross A.M., Alexander R.W., Stone G.W. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute MI: the AMISTAD-2 trial. Eur Heart J 2006, 27:2400-2405.
109. Koller A., Sun D., Kaley G. Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 1993, 72:1276-1284.
110. Komaru T., Lamping K.G., Eastham C.L., Dellsperger K.C. Role of ATP-sensitive potassium channels in coronary microvascular autoregulatory responses. Circ Res 1991, 69:1146-1151.
111. Komaru T., Kanatsuka H., Shirato K. Coronary microcirculation: physiology and pharmacology. Pharmacol Ther 2000, 86:217-261.
112. Kong D.F., Hasselblad V., Harrington R.A., White H.D., Tcheng J.E., Kandzari D.E., Topol E.J., Califf R.M. Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions. Am J Cardiol 2003, 92:651-655.
113. Kotani J., Nanto S., Mintz G.S., Kitakaze M., Ohara T., Morozumi T., Nagata S., Hori M. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002, 106:1672-1677.
114. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989 November, 80(5):1328-1337.
115. Kunichika H., Ben-Yehuda O., Lafitte S., Kunichika N., Peters B., DeMaria A.N. Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study. J Am Coll Cardiol 2004, 43:276-283.
116. Kuo L., Davis M.J., Chilian W.M. Myogenic activity in isolated subepicardial and subendocardial coronary arterioles. Am J Physiol 1988, 255:H1558-H1562.
117. Kuo L., Chilian W.M., Davis M.J. Coronary arteriolar myogenic response is independent of endothelium. Circ Res 1990, 66:860-866.
118. Kuo L., Davis M.J., Chilian W.M. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol 1990, 259:H1063-H1070.
119. Kuo L., Davis M.J., Chilian W.M. Longitudinal gradients for endothelium-dependent and -independent vascular responses in the coronary microcirculation. Circulation 1995, 92:518-525.
120. Kurz M.A., Lamping K.G., Bates J.N., Eastham C.L., Marcus M.L., Harrison D.G. Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin. Circ Res 1991, 68:847-855.
121. Lanza G.A., Giordano A., Pristipino C., Calcagni M.L., Meduri G., Trani C., Franceschini R., Crea F., Troncone L., Maseri A. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy. Circulation 1997, 96:821-826.
122. Lanza G.A., Sestito A., Iacovella S., Morlacchi L., Romagnoli E., Schiavoni G., Crea F., Maseri A., Andreotti F. Relation between platelet response to exercise and coronary angiographic findings in patients with effort angina. Circulation 2003, 107:1378-1382.
123. Laskey W.K. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 2005, 65:361-367.
124. Lee R.T., Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997, 17:1859-1867.
125. Lee C.H., Wong H.B., Tan H.C., Zhang J.J., Teo S.G., Ong H.Y., Low A., Sutandar A., Lim Y.T. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute MI-insights from a 1,328 patient registry. J Interv Cardiol 2005, 18:261-266.
126. Manning W.J., Atkinson D.J., Grossman W., Paulin S., Edelman R.R. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 1991, 18:959-965.
127. Manyari D.E., Knudtson M., Kloiber R., Roth D. Sequential Thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: delayed resolution of exercise-induced scintigraphic abnormalities. Circulation 1988, 77:86-95.
128. Marcus M., Wright C., Doty D., Eastham C., Laughlin D., Krumm P., Fastenow C., Brody M. Measurements of coronary velocity and reactive hyperemia in the coronary circulation of humans. Circ Res 1981, 49:877-891.
129. 2 supply. Microvasc Res 1969, 1:244-256.
130. Marzilli M., Sambuceti G., Fedele S., L'Abbate A. Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. J Am Coll Cardiol 2000, 35:327-334.
131. Marzilli M., Orsini E., Marraccini P., Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute MI. Circulation 2000, 101:2154-2159.
132. Marzilli M., Sambuceti G., Testa R., Fedele S. Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina. J Am Coll Cardiol 2002, 40:2102-2109.
133. Matsumura K., Jeremy R.W., Schaper J., Becker L.C. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 1998, 97:795-804.
134. Michaels A.D., Appleby M., Otten M.H., Dauterman K., Ports T.A., Chou T.M., Gibson C.M. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J Invasive Cardiol 2002, 14:299-302.
135. Miller F.J., Dellsperger K.C., Gutterman D.D. Myogenic constriction of human coronary arterioles. Am J Physiol 1997, 273:H257-H264.
136. + channels. Circulation 2001, 103:1992-1998.
137. Moncada S., Gryglewski R., Bunting S., Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976, 263:663-665.
138. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142.
139. Morrow D.A., Rifai N., Antman E.M., Weiner D.L., McCabe C.H., Cannon C.P., Braunwald E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in MI. J Am Coll Cardiol 1998, 31:1460-1465.
140. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
141. Nellis S.H., Liedtke A.J., Whitesell L. Small coronary vessel pressure and diameter in an intact beating rabbit heart using fixed-position and free-motion techniques. Circ Res 1981, 49:342-353.
142. Nelson M.T., Patlak J.B., Worley J.F., Standen N.B. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol 1990, 259:C3-C18.
143. Neumann F.J., Blasini R., Schmitt C., Alt E., Dirschinger J., Gawaz M., Kastrati A., Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute MI. Circulation 1998, 98:2695-2701.
144. Neumann F.J., Zohlnhofer D., Fakhoury L., Ott I., Gawaz M., Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute MI. J Am Coll Cardiol 1999, 34:1420-1426.
145. Nitenberg A., Valensi P., Sachs R., Dali M., Aptecar E., Attali J.R. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993, 42:1017-1025.
146. Okamura A., Ito H., Iwakura K., Kawano S., Inoue K., Maekawa Y., Ogihara T., Fujii K. Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute MI: efficacy of distal protection device. J Am Coll Cardiol 2005, 45:212-215.
147. Olafsson B., Forman M.B., Puett D.W., Pou A., Cates C.U., Friesinger G.C., Virmani R. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 1987, 76:1135-1145.
148. Ota S., Nishikawa H., Takeuchi M., Nakajima K., Nakamura T., Okamoto S., Setsuda M., Makino K., Yamakado T., Nakano T. Impact of nicorandil to prevent reperfusion injury in patients with acute MI: Sigmart Multicenter Angioplasty Revascularization Trial (SMART). Circ J 2006, 70:1099-1104.
149. Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1988, 333:664-666.
150. Park K.S., Kim Y., Lee Y.H., Earm Y.E., Ho W.K. Mechanosensitive cation channels in arterial smooth muscle cells are activated by diacylglycerol and inhibited by phospholipase C inhibitor. Circ Res 2003, 93:557-564.
151. Pasceri V., Pristipino C., Pelliccia F., Granatelli A., Speciale G., Roncella A., Pironi B., Capasso M., Richichi G. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute MI. Am J Cardiol 2005, 95:1358-1361.
152. Patel B., Smith L., Alahmar A., Browning P., Hart G., Fisher M. The inflammatory response post percutaneous coronary intervention is associated with increased microvascular resistance in patients with stable angina. Eur Heart J 2009, 30:248. (Abstract Supplement).
153. Patti G., Pasceri V., Colonna G., Miglionico M., Fischetti D., Sardella G., Montinaro A., Di S.G. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 2007, 49:1272-1278.
154. Petersen S.E., Jerosch-Herold M., Hudsmith L.E., Robson M.D., Francis J.M., Doll H.A., Selvanayagam J.B., Neubauer S., Watkins H. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007, 115:2418-2425.
155. Petronio A.S., Rovai D., Musumeci G., Baglini R., Nardi C., Limbruno U., Palagi C., Volterrani D., Mariani M. Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty. Eur Heart J 2003, 24:67-76.
156. Piana R.N., Paik G.Y., Moscucci M., Cohen D.J., Gibson C.M., Kugelmass A.D., Carrozza J.P., Kuntz R.E., Baim D.S. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994, 89:2514-2518.
157. Piek J.J., Boersma E., Voskuil M., di M.C., Schroeder E., Vrints C., Probst P., de B.B., Hanet C., Fleck E., Haude M., Verna E., Voudris V., Geschwind H., Emanuelsson H., Muhlberger V., Peels H.O., Serruys P.W. The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler endpoints balloon angioplasty trial Europe. Eur Heart J 2001, 22:1725-1732.
158. Piper H.M., Garcia-Dorado D., Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998, 38:291-300.
159. Pitarys C.J., Virmani R., Vildibill H.D., Jackson E.K., Forman M.B. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation 1991, 83:237-247.
160. Pitkanen O.P., Nuutila P., Raitakari O.T., Ronnemaa T., Koskinen P.J., Iida H., Lehtimaki T.J., Laine H.K., Takala T., Viikari J.S., Knuuti J. Coronary flow reserve is reduced in young men with IDDM. Diabetes 1998, 47:248-254.
161. Pries A.R., Habazettl H., Ambrosio G., Hansen P.R., Kaski J.C., Schachinger V., Tillmanns H., Vassalli G., Tritto I., Weis M., de Wit C., Bugiardini R. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc Res 2008, 80:165-174.
162. Przyklenk K., Bauer B., Ovize M., Kloner R.A., Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993, 87:893-899.
163. Rawitscher D., Levin T.N., Cohen I., Feldman T. Rapid reversal of no-reflow using abciximab after coronary device intervention. Cathet Cardiovasc Diagn 1997, 42:187-190.
164. Resnic F.S., Wainstein M., Lee M.K., Behrendt D., Wainstein R.V., Ohno-Machado L., Kirshenbaum J.M., Rogers C.D., Popma J.J., Piana R. No-reflow is an independent predictor of death and MI after percutaneous coronary intervention. Am Heart J 2003, 145:42-46.
165. Roffi M., Mukherjee D., Chew D.P., Bhatt D.L., Cho L., Robbins M.A., Ziada K.M., Brennan D.M., Ellis S.G., Topol E.J. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation 2002, 106:3063-3067.
166. Rosen S.D., Lorenzoni R., Kaski J.C., Foale R.A., Camici P.G. Effect of alpha1-adrenoceptor blockade on coronary vasodilator reserve in cardiac syndrome X. J Cardiovasc Pharmacol 1999, 34:554-560.
167. Ross R.S., Ueda K.E.I.J., Lichtlen P.R., Rees J.R. Measurement of myocardial blood flow in animals and man by selective injection of radioactive inert gas into the coronary arteries. Circ Res 1964, 15:28-41.
168. Ross A.M., Gibbons R.J., Stone G.W., Kloner R.A., Alexander R.W. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute MI (AMISTAD-II). J Am Coll Cardiol 2005, 45:1775-1780. For the AMISTAD-II Investigators.
169. Sakata Y., Kodama K., Ishikura F., Komamura K., Hasegawa S., Sakata Y., Hirayama A. Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute MI. Jpn Circ J 1997, 61:455-458.
170. Sambuceti G., Marzullo P., Giorgetti A., Neglia D., Marzilli M., Salvadori P., L'Abbate A., Parodi O. Global alteration in perfusion response to increasing oxygen consumption in patients with single-vessel coronary artery disease. Circulation 1994, 90:1696-1705.
171. Sambuceti G., Marzilli M., Marraccini P., Schneider-Eicke J., Gliozheni E., Parodi O., L'Abbate A. Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease. Circulation 1997, 95:2652-2659.
172. Sambuceti G., Marzilli M., Fedele S., Marini C., L'Abbate A. Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease: reversal by angioplasty. Circulation 2001, 103:2352-2360.
173. Sato K., Kanatsuka H., Sekiguchi N., Akai K., Wang Y., Sugimura A., Kumagai T., Komaru T., Shirato K. Effect of an ATP sensitive potassium channel opener, levcromakalim, on coronary arterial microvessels in the beating canine heart. Cardiovasc Res 1994, 28:1780-1786.
174. Saucedo J.F., Mehran R., Dangas G., Hong M.K., Lansky A., Kent K.M., Satler L.F., Pichard A.D., Stone G.W., Leon M.B. Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 2000, 35:1134-1141.
175. Schofer J., Montz R., Mathey D.G. Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol 1985, 5:593-598.
176. Schwartzkopff B., Mundhenke M., Strauer B.E. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia. J Am Coll Cardiol 1998, 31:1089-1096.
177. Selvanayagam J.B., Cheng A.S.H., Jerosch-Herold M., Rahimi K., Porto I., van Gaal W., Channon K.M., Neubauer S., Banning A.P. Effect of distal embolization on myocardial perfusion reserve after percutaneous coronary intervention: a quantitative magnetic resonance perfusion study. Circulation 2007, 116:1458-1464.
178. Serruys P.W., de F.P., Macaya C., Kokott N., Puel J., Vrolix M., Branzi A., Bertolami M.C., Jackson G., Strauss B., Meier B. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 2002, 287:3215-3222.
179. Shah A., Schelbert H.R., Schwaiger M., Henze E., Hansen H., Selin C., Huang S.C. Measurement of regional myocardial blood flow with N-13 ammonia and positron-emission tomography in intact dogs. J Am Coll Cardiol 1985, 5:92-100.
180. Shinozaki N., Ichinose H., Yahikozawa K., Shimada H., Hoshino K. Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute MI. Int Heart J 2007, 48:423-433.
181. Siebes M., Verhoeff B.J., Meuwissen M., de Winter R.J., Spaan J.A.E., Piek J.J. Single-wire pressure and flow velocity measurement to quantify coronary stenosis hemodynamics and effects of percutaneous interventions. Circulation 2004, 109:756-762.
182. Spaan J.A., Piek J.J., Hoffman J.I., Siebes M. Physiological basis of clinically used coronary hemodynamic indices. Circulation 2006, 113:446-455.
183. Staat P., Rioufol G., Piot C., Cottin Y., Cung T.T., L'Huillier I., Aupetit J.F., Bonnefoy E., Finet G., ndre-Fouet X., Ovize M. Postconditioning the human heart. Circulation 2005, 112:2143-2148.
184. Steinhausen M., Tillmanns H., Thederan H. Microcirculation of the epimyocardial layer of the heart. I. A method for in vivo observation of the microcirculation of superficial ventricular myocardium of the heart and capillary flow pattern under normal and hypoxic conditions. Pflugers Arch 1978, 378:9-14.
185. Stone G.W., Mehran R., Dangas G., Lansky A.J., Kornowski R., Leon M.B. Differential impact on survival of electrocardiographic Q-wave versus enzymatic MI after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation 2001, 104:642-647.
186. Stone G.W., Webb J., Cox D.A., Brodie B.R., Qureshi M., Kalynych A., Turco M., Schultheiss H.P., Dulas D., Rutherford B.D., Antoniucci D., Krucoff M.W., Gibbons R.J., Jones D., Lansky A.J., Mehran R. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation MI: a randomized controlled trial. JAMA 2005, 293:1063-1072.
187. Sutherland C.G., Fisher B.M., Frier B.M., Dargie H.J., More I.A., Lindop G.B. Endomyocardial biopsy pathology in insulin-dependent diabetic patients with abnormal ventricular function. Histopathology 1989, 14:593-602.
188. Tahk S.J., Choi B.J., Choi S.Y., Yoon M.H., Gwon H.C., Hong G.R., Kim Y.J., Hur S.H., Kim K.B., Koo B.K., Lee S.H., Yoon J. Distal protection device protects microvascular integrity during primary percutaneous intervention in acute MI: a prospective, randomized, multicenter trial. Int J Cardiol 2007.
189. Taniyama Y., Ito H., Iwakura K., Masuyama T., Hori M., Takiuchi S., Nishikawa N., Higashino Y., Fujii K., Minamino T. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute MI. J Am Coll Cardiol 1997, 30:1193-1199.
190. Tesfamariam B., Halpern W. Modulation of adrenergic responses in pressurized resistance arteries by flow. Am J Physiol 1987, 253:H1112-H1119.
191. Tesfamariam B., Brown M.L., Deykin D., Cohen R.A. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990, 85:929-932.
192. The Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559.
193. The ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572.
194. The EPIC, I Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994, 330:956-961.
195. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998, 339:1349-1357. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
196. Tillich G., Mendoza L., Wayland H., Bing R.J. Studies of the coronary microcirculation of the cat. Am J Cardiol 1971, 27:93-98.
197. Tillmanns H., Steinhausen M., Leinberger H., Thederan H., Kubler W. Pressure measurements in the terminal vascular bed of the epimyocardium of rats and cats. Circ Res 1981, 49:1202-1211.
198. Tomai F., Ribichini F., Ghini A.S., Ferrero V., Ando G., Vassanelli C., Romeo F., Crea F., Chiariello L. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. Eur Heart J 2005, 26:2099-2105.
199. Tona F., Caforio A.L.P., Montisci R., Gambino A., Angelini A., Ruscazio M., Toscano G., Feltrin G., Ramondo A., Gerosa G., Iliceto S. Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation 2006, 114. I-49.
200. Tonino P.A., De B.B., Pijls N.H., Siebert U., Ikeno F., Veer M., Klauss V., Manoharan G., Engstrom T., Oldroyd K.G., Ver Lee P.N., MacCarthy P.A., Fearon W.F. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009, 360:213-224.
201. Tune J.D., Gorman M.W., Feigl E.O. Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 2004, 97:404-415.
202. Uren N.G., Crake T., Lefroy D.C., de S.R., Davies G.J., Maseri A. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J Am Coll Cardiol 1993, 21:612-621.
203. Uren N.G., Marraccini P., Gistri R., de S.R., Camici P.G. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol 1993, 22:650-658.
204. Uren N.G., Melin J.A., De Bruyne B., Wijns W., Baudhuin T., Camici P.G. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994, 330:1782-1788.
205. Verma S., Anderson T.J. Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002, 105:546-549.
206. Vijayalakshmi K., Whittaker V.J., Kunadian B., Graham J., Wright R.A., Hall J.A., Sutton A., de Belder M.A. Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. Heart 2006, 92:1278-1284.
207. Vural K.M., Oz M.C. Endothelial adhesivity, pulmonary hemodynamics and nitric oxide synthesis in ischemia-reperfusion. Eur J Cardiothorac Surg 2000, 18:348-352.
208. Walsh S.R., Tang T.Y., Kullar P., Jenkins D.P., Dutka D.P., Gaunt M.E. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. European Journal of Cardio-Thoracic Surgery 2008, 34:985-994.
209. Wang H.J., Lo P.H., Lin J.J., Lee H., Hung J.S. Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute MI. Catheter Cardiovasc Interv 2004, 63:171-176.
210. Watkins S., McGeoch R., Lyne J., Steedman T., Good R., McLaughlin M.J., Cunningham T., Bezlyak V., Ford I., Dargie H.J., Oldroyd K.G. Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation 2009, 120:2207-2213.
211. Wegria R., Keating R.P., Ward H.P., Dreyfuss F., Frank C.W., Blumenthal M.R. Effect of auricular fibrillation on the coronary blood flow. Am J Physiol 1949, 160:177-182.
212. Wei K., Jayaweera A.R., Firoozan S., Linka A., Skyba D.M., Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998, 97:473-483.
213. Werner G.S., Lang K., Kuehnert H., Figulla H.R. Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute MI. Catheter Cardiovasc Interv 2002, 57:444-451.
214. Wilson R.F., Johnson M.R., Marcus M.L., Aylward P.E., Skorton D.J., Collins S., White C.W. The effect of coronary angioplasty on coronary flow reserve. Circulation 1988, 77:873-885.
215. Wilson R.F., Laxson D.D., Lesser J.R., White C.W. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet 1989, 1:807-811.
216. Yada T., Hiramatsu O., Kimura A., Goto M., Ogasawara Y., Tsujioka K., Yamamori S., Ohno K., Hosaka H., Kajiya F. In vivo observation of subendocardial microvessels of the beating porcine heart using a needle-probe videomicroscope with a CCD camera. Circ Res 1993, 72:939-946.
217. Yada T., Richmond K.N., van Bibber R., Kroll K., Feigl E.O. Role of adenosine in local metabolic coronary vasodilation. Am J Physiol Heart Circ Physiol 1999, 276:H1425-H1433.
218. Yamamuro A., Akasaka T., Tamita K., Yamabe K., Katayama M., Takagi T., Morioka S. Coronary flow velocity pattern immediately after percutaneous coronary intervention as a predictor of complications and in-hospital survival after acute MI. Circulation 2002, 106:3051-3056.
219. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
220. Yang X.C., Liu Y., Wang L.F., Cui L., Wang T., Ge Y.G., Wang H.S., Li W.M., Xu L., Ni Z.H., Liu S.H., Zhang L., Jia H.M., Vinten-Johansen J., Zhao Z.Q. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol 2007, 19:424-430.
221. Yarom R., Zirkin H., Stammler G., Rose A.G. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material. J Pathol 1992, 166:265-270.
222. Yokoyama I., Momomura S., Ohtake T., Yonekura K., Nishikawa J., Sasaki Y., Omata M. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997, 30:1472-1477.
223. Yoon M.H., Tahk S.J., Choi S.Y., Choi T.Y., Choi B.J., Choi J.H., Yoo S.Y., Ahn S.G., Zheng Z.G., Hwang G.S., Shin J.H. Effect of distal protection device on the microvascular integrity in acute MI during primary percutaneous coronary intervention. Circ J 2006, 70:1284-1289.
224. Zeiher A.M., Drexler H., Wollschlager H., Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991, 84:1984-1992.
225. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003, 285:H579-H588.